AzTrials
AzTrials

Sleep-related Respiratory DisorderNCT04448470

Daytime Sleepiness in Patients With the Assessment of a Sleep-related Respiratory Disorder

An observational study of Sleep-related Respiratory Disorder, run by Heinrich-Heine University, Duesseldorf at 2 sites in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

It is not yet known whether an analysis of daytime sleepiness over the course of the day can predict the diagnosis or severity of sleep apnea. The goal of the study is to examine whether a psychometric determination of daytime sleepiness can adequately and practicably record daytime sleepiness in patients with mainly… Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Sleep-related Respiratory Disorder
What is being tested?
Questionnaire for recording daytime sleepiness over the course of the day, Anamnesis and physicial examination and Questionnaire for quantifying daytime sleepiness
How many people
130 participants
Where
2 sitesGermany
Study dates
24 Jun 2020to 30 Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: patients with the clinical suspicion of sleep apnea and healthy subject The healthy subjects will be recruited at the Lung and Allergy Centre, Practice for Internal Medicine, Pneumology, Allergology, Sleep and Sports Medicine Neuss in the clinical routine. The patients are from the Lung and Allergy Centre, Practice for Internal Medicine, Pneumology, Allergology, Sleep and Sports Medicine in Neuss and from the Div. of Cardiology, Pulmonary Disease and Vascular Medicine from the University Hospital Düsseldorf.

Who may be able to join

  • Age 18-80 years
  • Written informed consent to participate in this study
  • Patients with a clinical suspicion of sleep apnea
  • Age 18-45 years
  • no internal or psychiatric illness requiring therapy
  • not long-term drug therapy
  • no known sleep apnea.
  • Written consent to participate in this study

Who cannot join

  • Age <18 years
  • Lack of consent to participate in the study
  • Lack of willingness and ability to participate in the study
  • Pregnancy and breast feeding period
  • Patients with sleep apnea
  • Age <18 years or ≥ 45 years
Show all 9Show fewer
  • Lack of consent to participate in the study
  • Pregnancy and breast feeding period
  • Lack of willingness and ability to participate in the study

Trial locations and contacts

2 sites in 1 country.

Stefanie Keymel, MD contact

+492118118800

ctsu@med.uni-duesseldorf.de

Rabea Wagstaff, M.A. contact

+492118118914

ctsu@med.uni-duesseldorf.de

Germany2 sites, 2 recruiting
  • Heinrich-Heine-University

    Düsseldorf, North Rhine-Westphalia, 40225

    Stefanie Keymel, MD, +492118118800, ctsu@med.uni-duesseldorf.de

    Rabea Wagstaff, M.A., ctsu@med.uni-duesseldorf.de

    Recruiting
  • Lung and Allergy Centre

    Neuss, North Rhine-Westphalia, 41462

    Johannes Uerscheln, MD

    Johannes Uerscheln, MD

    Recruiting

Other trials in Germany

About this study

Official title: Comparison Between the Situational and the Time-of-day Recording of Daytime Sleepiness in Patients With the Assessment of a Sleep-related Respiratory Disorder

It is not yet known whether an analysis of daytime sleepiness over the course of the day can predict the diagnosis or severity of sleep apnea. The goal of the study is to examine whether a psychometric determination of daytime sleepiness can adequately and practicably record daytime sleepiness in patients with mainly sleep apnea in comparison to other standardized methods.

Read the detailed description

Detailed Description: Sleep-related respiratory disorders are a common disease in the general population. Untreated sleep apnea is associated with an increased risk of accidents, an increased risk of perioperative complications and various cardiovascular diseases such as arterial hypertension, coronary heart disease or stroke. Sleep apnea is often undetected. As part of the diagnosis of sleep apnea, screening is usually carried out to assess the probability of pre-testing before a sleep medical examination by means of anamnesis, examination and recording of risk factors and comorbidities. Questionnaires play a decisive role here. The Epworth Sleepiness Scale (ESS) or the STOP BANG questionnaires are often used for this purpose. ESS asks about the probability of falling asleep in different situations. With STOP BANG, the points daytime tiredness, snoring, breathing stops and various risk factors such as age, sex, neck circumference, high blood pressure and overweight are asked. The quality of the questionnaire used to assess the risk of sleep apnea is of crucial importance, as it is usually the basis for the decision whether or not to perform further sleep medical diagnostics. To date, there is no established, easy-to-use method for measuring daytime sleepiness during the day. However, it can be assumed that the degree of daytime sleepiness can predict the presence of sleep apnea. In a proof-of-concept study, the psychometric determination of daytime sleepiness in a time series on one day in patients with mainly sleep apnea will be measured.

The following questions should be answered:

  1. Does daytime sleepiness in patients with sleep apnea measured by a scale-based, psychometric time-series test show one or more characteristic patterns over the day?
  2. Is there a relation between the degree of the scale based psychometric time series test for daytime sleepiness and the severity of sleep apnea?
  3. Is the test quality of the scale based psychometric time series test for predicting sleep apnea better than the established Epworth Sleepiness Scale or STOP BANG questionnaires.

The quantification of daytime sleepiness can potentially be of crucial importance both for diagnostic procedures and for the assessment of the use of therapeutic measures.

Being tested
Questionnaire for recording daytime sleepiness over the course of the day, Anamnesis and physicial examination, Questionnaire for quantifying daytime sleepiness, Pulmonary function test, Polygraphy
Keywords
daytime sleepiness, respiratory disorder, sleep apnea
Medical subject headings
Disorders of Excessive Somnolence, Respiration Disorders, Sleep Apnea Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire for recording daytime sleepiness over the course of the dayOther

    Questionnaire for recording daytime sleepiness over the course of the day

  • Anamnesis and physicial examinationOther

    Anamnesis and physical examination, e.g. medication, comorbidities, complaints

  • Questionnaire for quantifying daytime sleepinessOther

    the Epworth Sleepiness Scale (ESS) questionnaire and the STOP BANG Questionnaire

  • Pulmonary function testDiagnostic test

    The measured values of spirometry/body plethysmography, CO diffusion and blood gas analysis are documented, if available.

  • PolygraphyDiagnostic test

    Polygraphy is a non-invasive portable examination method that the patient uses in the home environment at night to measure possible sleep-related breathing disorders. Typically, the following measurement signals are recorded: nasal airflow, thoracic and abdominal breathing excursions, snoring and breathing sounds via a microphone, pulse, oxygen saturation and position. The evaluation results and the findings are checked by a physician. Essential parameters include the apnoea-hypopnoea index, the number of obstructive, central and mixed apnoea/hypopnoea, the number and duration of desaturation, snoring or the association with a certain position.

Study groups in NCT04448470
Study groupRoleWhat they receive
patients with a clinical suspicion of sleep apnea (n=150)patients with a clinical suspicion of sleep apnea
Receives: Other: Questionnaire for recording daytime sleepiness over the course of the day; Other: Anamnesis and physicial examination; Other: Questionnaire for quantifying daytime sleepiness; Diagnostic Test: Pulmonary function test; Diagnostic Test: Polygraphy
healthy subjects (n=10)healthy subjects
Receives: Other: Questionnaire for recording daytime sleepiness over the course of the day; Other: Anamnesis and physicial examination; Other: Questionnaire for quantifying daytime sleepiness; Diagnostic Test: Pulmonary function test; Diagnostic Test: Polygraphy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prediction of Sleep Apnea

    the degree of daytime sleepiness can predict the presence of sleep apnea the degree of daytime sleepiness can predict the presence of sleep apnea

    Measured: at Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2020
  2. Study start24 Jun 2020
  3. Primary completion30 Jun 2021 (estimated)
  4. Study completion30 Jun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
130 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04448470
Sponsor's protocol ID
19-002
Status last verified
Jun 2020
First submitted
24 Jun 2020
Last updated
25 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep-related Respiratory Disorder, run by Heinrich-Heine University, Duesseldorf at 2 sites in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Stefanie Keymel, MD (+492118118800, ctsu@med.uni-duesseldorf.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prediction of Sleep Apnea (time frame: at Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in